Introduction
Renal cell carcinoma (RCC) accounts for approximately 2%-4% of all human malignancies and is one of the most common cancers in urology. 1, 2 Because kidney diseases are mostly asymptomatic during the early stages, many RCC patients are diagnosed with advanced stage metastatic diseases that are often resistant to chemotherapy, and therefore this is associated with high mortality. 3 Despite the great advances made in the diagnosis and treatment of RCC, therapeutic options are limited and prognosis remains unfavorable. 4 Therefore, there is a need to identify effective biomarkers for predicting the progression and prognosis of RCC and to advance the development of new targeted therapies.
During the past decades, numerous studies have revealed that a large portion of the human genome is universally transcribed into noncoding RNAs (ncRNAs). 5 Long ncRNAs (lncRNAs) are RNA molecules that are larger than 200 nucleotides in length and with no protein coding capabilities. 6, 7 Recently, many studies have shown that lncRNAs are involved in carcinogenesis, including invasion and metastasis of kidney, submit your manuscript | www.dovepress.com
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ni et al breast, and colorectal cancers. [8] [9] [10] Particularly in RCC, it has been reported that high expression of lncRNA ATB promotes cell migration and invasion, and correlates with metastases, 11 while low expression of lncRNA NBAT-1 increases cell proliferation, migration, and invasion, and is also associated with poor prognosis. 12 In addition, many other lncRNAs, including TUG1, 13 BX357664, 14 and MEG3, 15 have been demonstrated to participate in the development and progression of RCC. Despite the identification of numerous lncRNAs in RCC, the majority remain unexplored, and this is therefore the reason for conducting this study.
Through in vitro experiments, Burgener et al 16 in 1990 discovered serum deprivation response (SDPR), also named cavin-2, located on chromosome 2q32-q33 as a substrate for protein kinase C isoforms. SDPR has been confirmed to be involved in inducing membrane curvature and caveolae formation, and it is strongly linked to gut electrophysiological pacing functions, cell proliferation, and migration. [17] [18] [19] Importantly, previous studies have indicated that SDPR is downregulated in kidney, prostate, and breast cancers. 20, 21 SDPR has also been reported to be a possible biomarker for early detection and discrimination of malignant kidney tumors. 22 Through bioinformatic analysis, we uncovered an lncRNA, termed AC098617.1, which is located at chromosome 2q32.3, ranging from 192,711,265 to 192,901,485, with the full length up to about 190,221 bp (data from UCSC website). AC098617.1 (Ensembl Gene ID: ENSG00000233766) with 13 transcripts is also known as LOC105373813 Gene or Uncharacterized LOC105373813. Of particular note is that the lncRNA is the antisense (AS) transcript of SDPR (SDPR-AS) and is located on the upstream of the gene. The expression and functions of lncRNAs are often associated with their adjacent protein coding genes. 23 It is therefore tempting to speculate that the expression and functions of SDPR-AS may also be associated with the progression and prognosis of RCC. In this study, we first investigated the expression profiles of SDPR-AS and SDPR in RCC. Subsequently, the functional roles of SDPR-AS in RCC cells were evaluated. Additionally, the correlations between SDPR-AS expression and clinical variables, as well as prognosis, were examined.
Materials and methods statement of ethics
The tissue specimens and clinical materials used in this study were collected after each participant gave written informed consent, which was in accordance with our institutional ethical guidelines. The ethical committee of the Chinese People's Liberation Army (PLA) General Hospital approved the utilization of tumor tissues for this study.
Patients and samples
In total, 56 RCC patients who underwent initial surgery at the Chinese PLA General Hospital between 2005 and 2007 were enrolled into this research. Tumor and adjacent normal tissues were immediately snap-frozen in liquid nitrogen after resection, then maintained at -80°C until use.
cell culture
The human RCC cell lines, OS-RC-2, 786-O, 769-P, Caki-1, Caki-2, and ACHN, as well as normal renal cell line HKC were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). All cells were cultured in Dulbecco's Modified Eagle's Medium (Hyclone, UT, USA), containing 10% heat-inactivated fetal bovine serum, penicillin (100 U/mL), and streptomycin (100 μg/mL) in a 5% CO 2 and humidified atmosphere at 37°C.
sDPr-as overexpression experiments
The universally available pcDNA3.1 vector was used for cDNA-SDPR-AS plasmid construction. Following the manufacturer's instructions, the SDPR-AS low-expressing OS-RC-2 cells were transfected with pcDNA-SDPR-AS using Lipofectamine 2000 (Invitrogen). The transfected cells were harvested for RNA isolation and functional assays.
sDPr-as knockdown experiments
Small interfering RNAs (siRNAs) for the target SDPR-AS (SDPR-AS-si) and negative-control siRNAs (NC-si) were obtained from GenePharma (Shanghai, People's Republic of China), and the sequences are listed in Table 1 . The SDPR-AS high-expressing 769-P cell line was selected for transfection with SDPR-AS-si. Prior to transfection, 12-well plates were seeded with approximately 50% of the cells and cultured for 24 h. Then, siRNA transfections were carried out with X-treme GENE transfection reagents (Roche) according to the manufacturer's instructions. RNA was isolated after 48 h of transfection and used to perform functional assays.
rna isolation and reverse transcription
Total RNA was isolated from cells and tissues using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. NanoDrop ND2000 (Thermo Scientific Inc., Santa Clara, CA, USA) was used to determine the purity and quantify the concentration of RNA. 
real-time quantitative polymerase chain reaction
Primers used for real-time quantitative polymerase chain reaction (RT-qPCR) were obtained from GenePharma (Shanghai, People's Republic of China), and the sequences are listed in Table 1 . According to the manufacturer's instructions, RT-qPCR was performed using the SYBR PrimeScript RT-PCR kit (Takara) in an Applied Biosystems 7500 fluorescent quantitative PCR system (Applied Biosystems, Foster City, CA, USA). The reaction started at 95°C for 5 min, followed by 40 cycles of 95°C for 30 s, 59°C for 30 s, and 72°C for 30 s. GAPDH was used as the internal reference to normalize qPCR results. Relative gene expression levels were measured using cycle threshold (CT) in the ΔΔCT calculation.
cell proliferation assay
The CCK8 assay was used to examine the proliferation of RCC cells. After 48 h of transfection, cells were seeded into 96-well plates together with the CCK8 reagent and incubated for 1 h at 37°C. The Tecan infinite M200 multimode microplate reader (Tecan, Mechelen, Belgium) was then used to detect cell density at 450 nm absorption wavelength. All experiments were performed in triplicate.
scratch wound-healing assay
The scratch wound-healing assay was used to evaluate the migratory properties of RCC cells. Cells were seeded into 12-well plates to achieve a confluent monolayer after 48 h of transfection. Then, uniform wounds were scraped with sterile 200 μL pipette tips. To remove floating cells, each well was washed thrice with PBS. The initial distance (0 h) and the distances traveled by cells after 24, 48, and 72 h of scratching were detected microscopically.
cell invasion assay
Transwell assays were conducted with 8 mm pore size Matrigel Invasion Chambers (Millipore Corporation, Billerica, MA, USA) to evaluate the invasive properties of RCC cells. After 48 h of transfection, single-cell suspensions were seeded into the upper chamber, with the lower chamber filled with 600 μL Dulbecco's Modified Eagle's Medium containing 10% fetal bovine serum. After 24-48 h of incubation, the noninvading cells were wiped off from the upper surface of the membranes, whereas cells that had invaded were stained with 0.5% crystal violet solution after cell fixation in 95% methyl aldehyde. The images of migrated cells per well were captured and counted in random fields using a microscope. Each experiment was conducted in triplicate.
statistical analyses
Statistical analyses were performed with SPSS version 18.0 (SPSS, Chicago, IL, USA). All experiments mentioned above were repeated three times, and data were presented as mean ± standard deviation. Two-tailed t-test and χ 2 test were used for comparisons between different groups. Kaplan-Meier estimator was used to perform survival analysis. P,0.05 was considered statistically significant.
Results
Downregulation of both sDPr-as and SDPR expression in rcc tissue samples
The expression levels of SDPR-AS and its protein coding gene SDPR were examined by RT-qPCR in panel-paired specimens obtained from the 56 patients with RCC. Compared to the matched normal tissues, the expression levels of SDPR-AS ( Figure 1A , ***P,0.001) and SDPR ( Figure 1B , ***P,0.001) in tumor tissues were significantly downregulated. SDPR expression was coregulated with sDPr-as overexpression or knockdown in rcc cell lines RT-qPCR was performed to determine the expression levels of SDPR-AS and SDPR in six RCC cell lines (OS-RC-2, 786-O, 769-P, Caki-1, Caki-2, and ACHN) and the normal cell line (HKC). The results indicated that the expression levels of SDPR-AS and SDPR were significantly lower in the six RCC cell lines compared to the normal HKC cell line ( Figure 3A and B, *P,0.05). In addition, as shown in Figure 3A and B, among the six RCC cell lines, the expression levels of SDPR-AS and SDPR were highest in the 769-P and lowest in the OS-RC-2 cell lines. After being transfected with pcDNA-SDPR-AS plasmid, SDPR-AS was overexpressed in the OS-RC-2 cell line, while the expression level of SDPR was apparently upregulated ( Figure 3C , *P,0.05). On the contrary, SDPR and SDPR-AS expressions were significantly decreased in the 769-P cell line transfected with SDPR-AS-si ( Figure 3D , *P,0.05). The data indicated that SDPR and SDPR-AS were coregulated in the RCC cell lines.
Overexpression of sDPr-as suppressed the migration and invasion of Os-rc-2 cell line but had no evident association with proliferation
To further investigate the functional role of SDPR-AS, we examined its effects on OS-RC-2 cells transfected with pcDNA-SDPR-AS or the pcDNA control. There was no significant difference in the growth of OS-RC-2 cells transfected with either pcDNA-SDPR-AS or pcDNA control ( Figure 4A ). However, the wound healing assay showed significant inhibition of cell migration by pcDNA-SDPR-AS compared to pcDNA control ( Figure 4B , *P,0.05). The matrigel invasion assay also revealed remarkable suppression of cell invasion by pcDNA-SDPR-AS compared to pcDNA control ( Figure 4C , *P,0.05).
Knockdown of sDPr-as promoted the migration and invasion of 769-P cell line but showed no evident association with proliferation
To further validate the functional role of SDPR-AS in RCC cells, we performed knockdown experiments by transfecting 
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Downregulation of lncrna sDPr-as is associated with poor prognosis the 769-P cell line with SDPR-AS-si or NC si and examined their effects on cellular activity. There was no evident difference in proliferation of 769-P cells transfected with either SDPR-AS-si or NC si ( Figure 5A ). The wound healing and matrigel invasion assays, however, revealed significantly enhanced migration and invasion abilities of 769-P cells treated with SDPR-AS-si compared with those treated with NC si ( Figure 5B and C, *P,0.05).
correlation analyses of sDPr-as expression and clinical variables of rcc patients
Studies were carried out to assess the correlation between SDPR-AS and clinical characteristics of RCC patients.
The statistical analysis revealed an evident association of SDPR-AS expression levels with differentiation grade, tumor node metastasis (TNM) stage, and lymph node metastasis (Table 2) . However, no statistically significant associations were found in other clinicopathological features, including age, tumor size, and tumor location.
The association between sDPr-as expression and prognosis of rcc patients
Kaplan-Meier survival and log-rank tests were performed to determine the association between SDPR-AS expression and prognosis. The overall expression levels of SDPR-AS were classified based on the mean relative expression ratio 
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Downregulation of lncrna sDPr-as is associated with poor prognosis understood. In the present study, we analyzed the functional roles of the lncRNA SDPR-AS and its prognostic relevance in RCC. Recently, a number of studies have demonstrated that AS lncRNAs can regulate their sense mRNA partners in a discordant or concordant fashion. 29, 30 Numerous AS lncRNAs have been identified to be associated with a variety of malignant tumors. 31, 32 Generally, they modulate their sense partners by epigenetic regulation at the promoter regions or through other mechanisms. 33, 34 lncRNA SDPR-AS is the AS partner of the mRNA of SDPR. It has also been demonstrated that SDPR is an important tumor suppressor in certain cancers, including prostate cancer, 20, 35 breast cancer, 21, 36 and hepatocellular carcinoma. 37 In particular, a previous study reported that SDPR was remarkably downregulated in RCC cells, 22 which sparked our interest in conducting this study to investigate the functional and prognostic roles of its AS lncRNA in RCC.
In the present study, we first demonstrated the significant downregulation of SDPR-AS in RCC tissues in comparison to their matched nontumorous tissues. By loss-of-function and gain-of-function approaches, we confirmed that SDPR-AS played a critical role in cell migration and invasion, but had no evident effect on cell proliferation. In addition, the results also demonstrated a positive correlation between SDPR and SDPR-AS expression. Based on clinical data analysis, we determined that low expression of SDPR-AS was associated with tumor differentiation grade, TNM stage and in RCC tissue specimens as high (SDPR-AS expression ratio $ median ratio, n=21) and low (SDPR-AS expression ratio # median ratio, n=35). The data suggested that high expression of SDPR-AS was significantly associated with increased overall survival, whereas low expression indicated poor overall survival outcomes. Thus, SDPR-AS expression may be associated with prognosis of RCC patients ( Figure 6 , *P,0.05).
Discussion
Dozens of lncRNAs have recently been discovered through RNA sequencing and are annotated by the GENCODE project. 24 Interest has been generated as a result of the fact that numerous lncRNAs are strongly linked with various cancers. For example, Chen et al 9 reported that long intergenic noncoding RNA ROR (lincRNA-ROR) was involved in breast cancer invasion through participating in the epithelialmesenchymal transition process. Huang et al 25 demonstrated that low expression of DGCR5 was an important negative prognostic factor for hepatocellular carcinoma. In RCC, a number of lncRNAs, including CRNDE, 26 TCL6, 27 and MALAT-1 28 have been reported to be aberrantly expressed. Although alterations of lncRNAs in RCC have already been recognized, the functional roles of many remain to be 
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ni et al lymph node metastasis. However, no statistically significant associations were found in other clinicopathological features, including age, tumor size, and tumor location. Furthermore, a multivariate analysis suggested that SDPR-AS expression level could serve as an independent prognostic predictor for RCC. Taken together, these results revealed a key role of SDPR-AS in RCC metastasis, possibly through modulation of the levels and functions of its sense partner. To our knowledge, our data may provide the first evidence for clarifying the functional and prognostic roles of SDPR-AS in RCC.
Conclusion
This study revealed the molecular mechanistic insights of SDPR-AS in RCC. In addition, this study provides some evidence that SDPR-AS may act as an independent prognostic predictor of RCC patients.
